X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22196) 22196
Newspaper Article (979) 979
Newsletter (110) 110
Magazine Article (49) 49
Book Chapter (33) 33
Trade Publication Article (19) 19
Book / eBook (10) 10
Publication (9) 9
Conference Proceeding (6) 6
Book Review (4) 4
Web Resource (4) 4
Dissertation (2) 2
Reference (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14184) 14184
female (7440) 7440
male (7385) 7385
animals (7212) 7212
polyethylene glycols - therapeutic use (6446) 6446
polyethylene glycol (6299) 6299
polyethylene glycols - chemistry (5583) 5583
pharmacology & pharmacy (4986) 4986
middle aged (4531) 4531
adult (4237) 4237
interferon-alpha - therapeutic use (4139) 4139
antiviral agents - therapeutic use (3879) 3879
nanoparticles (3811) 3811
treatment outcome (3614) 3614
mice (3471) 3471
drug delivery systems (3234) 3234
ribavirin - therapeutic use (3117) 3117
hepatitis c, chronic - drug therapy (2858) 2858
cancer (2825) 2825
recombinant proteins (2759) 2759
drug therapy, combination (2660) 2660
polyethylene glycols - administration & dosage (2628) 2628
aged (2565) 2565
gastroenterology & hepatology (2327) 2327
polyethylene glycols (2142) 2142
therapy (2117) 2117
analysis (2107) 2107
recombinant proteins - therapeutic use (2059) 2059
drugs (2046) 2046
chemistry, multidisciplinary (2033) 2033
cell line, tumor (2008) 2008
rats (1862) 1862
drug-delivery (1811) 1811
nanoscience & nanotechnology (1782) 1782
polyethylene glycols - adverse effects (1720) 1720
materials science, biomaterials (1691) 1691
care and treatment (1689) 1689
health aspects (1647) 1647
polymers (1647) 1647
oncology (1640) 1640
proteins (1621) 1621
chemotherapy (1613) 1613
hepatitis c (1594) 1594
particle size (1588) 1588
in-vitro (1563) 1563
engineering, biomedical (1536) 1536
research (1517) 1517
interferon (1496) 1496
ribavirin (1481) 1481
hepacivirus - genetics (1472) 1472
nanoparticles - chemistry (1449) 1449
tumors (1436) 1436
medicine (1422) 1422
genotype (1397) 1397
delivery (1393) 1393
drug carriers - chemistry (1383) 1383
vehicles (1330) 1330
polyethylene glycols - pharmacology (1320) 1320
micelles (1264) 1264
time factors (1220) 1220
hydrogels (1186) 1186
polyethylene-glycol (1181) 1181
liposomes (1172) 1172
polyethylene (1154) 1154
drug delivery (1151) 1151
in-vivo (1143) 1143
poly (1135) 1135
polyols (1113) 1113
cells (1080) 1080
pharmacokinetics (1080) 1080
drug therapy (1079) 1079
doxorubicin (1060) 1060
solubility (1050) 1050
interferon-alpha - adverse effects (1037) 1037
antiviral agents - adverse effects (1034) 1034
hepatitis c virus (1034) 1034
toxicity (1033) 1033
mice, inbred balb c (1032) 1032
interferon-alpha - administration & dosage (1028) 1028
hepatitis c - drug therapy (1010) 1010
cytotoxicity (1005) 1005
biocompatibility (977) 977
biotechnology & applied microbiology (977) 977
biochemistry & molecular biology (968) 968
polymers - chemistry (960) 960
pharmacy (956) 956
hepatitis c, chronic - virology (948) 948
nanotechnology (931) 931
peptides (929) 929
surgery (914) 914
medicine, research & experimental (907) 907
cancer therapies (903) 903
research article (901) 901
viral load (901) 901
antiviral agents - administration & dosage (897) 897
ethylene glycol (897) 897
cell survival - drug effects (895) 895
young adult (887) 887
retrospective studies (884) 884
doxorubicin - administration & dosage (877) 877
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (22594) 22594
German (167) 167
Japanese (162) 162
Chinese (152) 152
Spanish (133) 133
French (107) 107
Russian (93) 93
Hungarian (36) 36
Polish (34) 34
Korean (29) 29
Italian (22) 22
Portuguese (16) 16
Danish (12) 12
Croatian (10) 10
Czech (8) 8
Dutch (8) 8
Norwegian (4) 4
Turkish (4) 4
Bulgarian (3) 3
Serbian (3) 3
Ukrainian (3) 3
Arabic (2) 2
Finnish (2) 2
Hebrew (2) 2
Romanian (2) 2
Slovak (2) 2
Icelandic (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Investigation, ISSN 0021-9738, 01/2011, Volume 121, Issue 1, pp. 308 - 317
...) as an important negative prognostic biomarker Given that CXCL10 mediates chemoattraction of activated lymphocytes, it is counter-intuitive that this chemokine correlates with therapeutic... 
MEDICINE, RESEARCH & EXPERIMENTAL | LIVER INFLAMMATION | GAMMA-INDUCIBLE PROTEIN-10 | VIRUS-INFECTION | DIPEPTIDYL-PEPTIDASE-IV | ANTIVIRAL THERAPY | INSULIN-RESISTANCE | IMMUNE-RESPONSES | CHRONIC HEPATITIS-C | LEVELS CORRELATE | PEGINTERFERON PLUS RIBAVIRIN | Chemokine CXCL10 - blood | Prognosis | Antiviral Agents - therapeutic use | Receptors, CXCR3 - blood | Humans | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Chemokine CXCL10 - antagonists & inhibitors | Dipeptidyl Peptidase 4 - blood | Hepatitis C, Chronic - virology | Hepatitis C, Chronic - therapy | Recombinant Proteins | Hepatitis C, Chronic - blood | Polyethylene Glycols - therapeutic use | T-Lymphocytes - virology | Treatment Failure | Hepatitis C, Chronic - immunology | Peptide Fragments - blood | Protein Array Analysis | T-Lymphocytes - immunology | Proteases | Physiological aspects | Research | Diagnosis | Hepatitis C | Drug therapy | Chemokines | Hepatitis C, Chronic/therapy | T-Lymphocytes/immunology | Polyethylene Glycols/therapeutic use | Dipeptidyl Peptidase 4/blood | Receptors, CXCR3/blood | Chemokine CXCL10/blood | T-Lymphocytes/virology | Hepatitis C, Chronic/blood | Interferon-alpha/therapeutic use | Chemokine CXCL10/antagonists & inhibitors | Life Sciences | Immunology | Antiviral Agents/therapeutic use | Hepatitis C, Chronic/immunology | Peptide Fragments/blood | Ribavirin/therapeutic use | Hepatitis C, Chronic/virology
Journal Article
Cochrane library, ISSN 1465-1858, 2016, Volume 2018, Issue 8, p. CD009118
Background Constipation within childhood is an extremely common problem. Despite the widespread use of osmotic and stimulant laxatives by health professionals... 
Childhood constipation and soiling | Polyethylene Glycols | Lactulose | Gastroenterology & hepatology | Mineral Oil | Treatment Outcome | Osmosis | Magnesium Hydroxide | Enema | Randomized Controlled Trials as Topic | OTHER | Sennosides | Senna Extract | Child health | Gastroenterology | Functional bowel disorders | Dietary Fiber | Laxatives | Medicine General & Introductory Medical Sciences | Constipation | Defecation | CONTROLLED-TRIAL | MAGNESIUM-HYDROXIDE | Dietary Fiber [adverse effects; therapeutic use] | Humans | Child, Preschool | Infant | PSYLLIUM FIBER | Mineral Oil [adverse effects; therapeutic use] | MEDICINE, GENERAL & INTERNAL | Polyethylene Glycols [adverse effects; therapeutic use] | POLYETHYLENE-GLYCOL 3350 | Child | Lactulose [adverse effects; therapeutic use] | HYDROLYZED GUAR GUM | PLUS ELECTROLYTES | Laxatives [adverse effects; therapeutic use] | LIQUID PARAFFIN | Constipation [drug therapy] | Magnesium Hydroxide [adverse effects; therapeutic use] | Defecation [drug effects; physiology] | CHRONIC FUNCTIONAL CONSTIPATION | Sugar Alcohols [adverse effects; therapeutic use] | Adolescent | DOUBLE-BLIND | RECTAL FECAL IMPACTION | Polyethylene Glycols - adverse effects | Male | Laxatives - therapeutic use | Polyethylene Glycols - therapeutic use | Laxatives - adverse effects | Senna Extract - therapeutic use | Dietary Fiber - therapeutic use | Senna Extract - adverse effects | Mineral Oil - adverse effects | Dietary Fiber - adverse effects | Mineral Oil - therapeutic use | Female | Constipation - drug therapy | Lactulose - therapeutic use | Infant, Newborn | Lactulose - adverse effects | Defecation - drug effects | Magnesium Hydroxide - adverse effects | Magnesium Hydroxide - therapeutic use
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 10/2014, Volume 136, Issue 41, pp. 14323 - 14332
.... This perspective presents a summary of protein–PEG conjugates for therapeutic use and alternative technologies in various stages of development as well as suggestions for future directions. Established methods of producing protein–PEG conjugates and new approaches utilizing controlled radical polymerization are also covered. 
LIVING RADICAL POLYMERIZATION | IN-SITU GROWTH | FRAGMENTATION CHAIN TRANSFER | POLY(ETHYLENE GLYCOL) | DRUG-DELIVERY | BIOLOGICAL EVALUATION | POLYETHYLENE-GLYCOL CONJUGATION | TREHALOSE GLYCOPOLYMERS | CHEMISTRY, MULTIDISCIPLINARY | RAFT POLYMERIZATION | IMMUNOLOGICAL-PROPERTIES | Proteins - metabolism | Models, Molecular | Polymerization | Polyethylene Glycols - chemistry | Molecular Structure | Proteins - chemistry | Polyethylene Glycols - therapeutic use | Conjugate vaccines | Health aspects | Analysis | Protein binding
Journal Article
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2014, Volume 32, Issue 13, pp. 1302 - 1308
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 03/2015, Volume 10, pp. 1791 - 1804
...), its application has been hindered by poor cellular uptake and unsatisfactory therapeutic effect... 
Phospholipid | Murine breast cancer chemotherapy | Nanoparticles PEG-b-PCL | Paclitaxel | nanoparticles PEG-b-PCL | paclitaxel | POLYMERIC MICELLE FORMULATION | CREMOPHOR-FREE | murine breast cancer chemotherapy | NANOSCIENCE & NANOTECHNOLOGY | GENEXOL-PM | PHASE-II TRIAL | PH-SENSITIVE LIPOSOMES | IN-VIVO | PHARMACOLOGY & PHARMACY | ANTICANCER DRUGS | phospholipid | CHAIN-LENGTH | TARGETED DELIVERY | Cell Survival - drug effects | Paclitaxel - pharmacology | Nanoparticles - chemistry | Polyethylene Glycols - pharmacokinetics | Polyethylene Glycols - chemistry | Antineoplastic Agents - therapeutic use | Paclitaxel - pharmacokinetics | Antineoplastic Agents - chemistry | Breast Neoplasms - drug therapy | Paclitaxel - therapeutic use | Polyethylene Glycols - therapeutic use | Lactones - pharmacology | Lactones - therapeutic use | Paclitaxel - chemistry | Animals | Lactones - pharmacokinetics | Nanoparticles - therapeutic use | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Mice | Drug Delivery Systems - methods | Lactones - chemistry | Polyethylene Glycols - pharmacology | Nanoparticles | Drugs | Usage | Drug delivery systems | Breast cancer | Research | Chemical properties | Drug therapy | Vehicles | Biomedical materials | Nuclear magnetic resonance--NMR | Polyethylene glycol | Efficiency | Lipids | FDA approval | Polymers | Cholesterol | Chromatography
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 02/2013, Volume 166, Issue 1, pp. 1 - 9
... that often involve intraperitoneal (IP) injection. Poly(ethylene glycol)-block-poly(ε-caprolactone) (PEG-b-PCL) micelles were loaded with paclitaxel... 
Bioluminescence imaging | PET imaging | Polymeric micelles | Paclitaxel | Combination drug delivery | Ovarian cancer | SYSTEM | CELLS | EFFICACY | CHEMISTRY, MULTIDISCIPLINARY | CHEMOTHERAPY | THERAPY | INHIBITION | RESISTANCE | PHARMACOLOGY & PHARMACY | Veratrum Alkaloids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Gossypol - therapeutic use | Paclitaxel - pharmacology | Antineoplastic Combined Chemotherapy Protocols - chemistry | Humans | Ovarian Neoplasms - pathology | Polyethylene Glycols - chemistry | Drug Carriers - chemistry | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Paclitaxel - chemistry | Micelles | Surface Properties | Veratrum Alkaloids - pharmacology | Female | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Lactones - chemistry | Cell Survival - drug effects | Veratrum Alkaloids - therapeutic use | Injections, Intraperitoneal | Kaplan-Meier Estimate | Solubility | Treatment Outcome | Paclitaxel - therapeutic use | Veratrum Alkaloids - chemistry | Xenograft Model Antitumor Assays | Gossypol - pharmacology | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice, Nude | Cell Line, Tumor | Mice | Gossypol - chemistry | Gossypol - administration & dosage | Drugs | Ethylene glycol | Drug delivery systems | Polyethylene | Care and treatment | Models | Drug therapy, Combination | Gossypol | Cancer | Vehicles | paclitaxel | polymeric micelles | combination drug delivery | ovarian cancer
Journal Article
Biomaterials, ISSN 0142-9612, 2011, Volume 32, Issue 18, pp. 4293 - 4305
Journal Article